Loading…
Vaccine Against Covid-19 Disease – Present Status of Development
The pandemic declaration of Covid-19 disease by World Health Organization (WHO) and subsequent widespread morbidities and mortalities in almost all countries of the world led to the research and development to find out a vaccine against SARS-CoV2 virus. Normally any new vaccine development takes 10–...
Saved in:
| Published in: | Indian journal of pediatrics 2020-10, Vol.87 (10), p.810-816 |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3 |
| container_end_page | 816 |
| container_issue | 10 |
| container_start_page | 810 |
| container_title | Indian journal of pediatrics |
| container_volume | 87 |
| creator | Dutta, Ashok Kumar |
| description | The pandemic declaration of Covid-19 disease by World Health Organization (WHO) and subsequent widespread morbidities and mortalities in almost all countries of the world led to the research and development to find out a vaccine against SARS-CoV2 virus. Normally any new vaccine development takes 10–15 y time but the search for vaccine against SARS-CoV2 is going on at a very fast pace resulting in almost breakthrough in vaccine development by several research institutions and vaccine manufacturers. In pandemic situation, however, the entire process of vaccine development including clinical trials gets shortened and may be fast tracked to 15–18 mo time. It is expected that there shall be simultaneous marketing of several vaccines by the beginning of 2021. There are more than 164 candidate vaccines which are in the process of development and among them 24 vaccines are in advanced stages of development. This review aims at highlighting the present stages of development of vaccines and discussing the challenges that may be faced with these novel vaccines. |
| doi_str_mv | 10.1007/s12098-020-03475-w |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7468088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2439975113</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3</originalsourceid><addsrcrecordid>eNp9kM1OHDEMxyPUCij0BXqo5thLivM9uVSiSz-QkEAq6jXKZDzbQbOTbTKziBvvwBv2SUhZQO2Fky3777_tHyHvGHxkAOYoMw62psCBgpBG0esdsg_WCGq0Fa9KDsxSJZXeI29yvgLgFrTdJXuC1zXUzO6Tzz99CP2I1fHS92OeqkXc9C1ltjrpM_qM1Z_bu-oiYcZxqn5MfppzFbvqBDc4xPWqVA_J684PGd8-xgNy-fXL5eI7PTv_dro4PqNBMT5R1bZeWBmaOshWdrpT4BVq2TaSNSA7ZgRwUy5EHWrdSsaxa5Q2XpramyAOyKet7XpuVtiGsjn5wa1Tv_LpxkXfu_87Y__LLePGGanLs3Ux-PBokOLvGfPkVn0OOAx-xDhnx6Ww1ijGRJHyrTSkmHPC7nkNA_eXvduyd4W9e2DvrsvQ-38PfB55gl0EYivIpTUuMbmrOKexMHvJ9h4zTZD0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2439975113</pqid></control><display><type>article</type><title>Vaccine Against Covid-19 Disease – Present Status of Development</title><source>Springer Link</source><creator>Dutta, Ashok Kumar</creator><creatorcontrib>Dutta, Ashok Kumar</creatorcontrib><description>The pandemic declaration of Covid-19 disease by World Health Organization (WHO) and subsequent widespread morbidities and mortalities in almost all countries of the world led to the research and development to find out a vaccine against SARS-CoV2 virus. Normally any new vaccine development takes 10–15 y time but the search for vaccine against SARS-CoV2 is going on at a very fast pace resulting in almost breakthrough in vaccine development by several research institutions and vaccine manufacturers. In pandemic situation, however, the entire process of vaccine development including clinical trials gets shortened and may be fast tracked to 15–18 mo time. It is expected that there shall be simultaneous marketing of several vaccines by the beginning of 2021. There are more than 164 candidate vaccines which are in the process of development and among them 24 vaccines are in advanced stages of development. This review aims at highlighting the present stages of development of vaccines and discussing the challenges that may be faced with these novel vaccines.</description><identifier>ISSN: 0019-5456</identifier><identifier>EISSN: 0973-7693</identifier><identifier>DOI: 10.1007/s12098-020-03475-w</identifier><identifier>PMID: 32880819</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>Betacoronavirus - immunology ; Biomedical Research ; Coronavirus Infections - immunology ; Coronavirus Infections - prevention & control ; Coronavirus Infections - virology ; COVID-19 ; COVID-19 Vaccines ; Drug Development ; Gynecology ; Humans ; Medicine ; Medicine & Public Health ; Pandemics - prevention & control ; Pediatrics ; Pneumonia, Viral - immunology ; Pneumonia, Viral - prevention & control ; Pneumonia, Viral - virology ; Review ; Review Article ; SARS-CoV-2 ; Vaccines ; Viral Vaccines - chemistry ; Viral Vaccines - immunology ; World Health Organization</subject><ispartof>Indian journal of pediatrics, 2020-10, Vol.87 (10), p.810-816</ispartof><rights>Dr. K C Chaudhuri Foundation 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3</citedby><cites>FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32880819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dutta, Ashok Kumar</creatorcontrib><title>Vaccine Against Covid-19 Disease – Present Status of Development</title><title>Indian journal of pediatrics</title><addtitle>Indian J Pediatr</addtitle><addtitle>Indian J Pediatr</addtitle><description>The pandemic declaration of Covid-19 disease by World Health Organization (WHO) and subsequent widespread morbidities and mortalities in almost all countries of the world led to the research and development to find out a vaccine against SARS-CoV2 virus. Normally any new vaccine development takes 10–15 y time but the search for vaccine against SARS-CoV2 is going on at a very fast pace resulting in almost breakthrough in vaccine development by several research institutions and vaccine manufacturers. In pandemic situation, however, the entire process of vaccine development including clinical trials gets shortened and may be fast tracked to 15–18 mo time. It is expected that there shall be simultaneous marketing of several vaccines by the beginning of 2021. There are more than 164 candidate vaccines which are in the process of development and among them 24 vaccines are in advanced stages of development. This review aims at highlighting the present stages of development of vaccines and discussing the challenges that may be faced with these novel vaccines.</description><subject>Betacoronavirus - immunology</subject><subject>Biomedical Research</subject><subject>Coronavirus Infections - immunology</subject><subject>Coronavirus Infections - prevention & control</subject><subject>Coronavirus Infections - virology</subject><subject>COVID-19</subject><subject>COVID-19 Vaccines</subject><subject>Drug Development</subject><subject>Gynecology</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pandemics - prevention & control</subject><subject>Pediatrics</subject><subject>Pneumonia, Viral - immunology</subject><subject>Pneumonia, Viral - prevention & control</subject><subject>Pneumonia, Viral - virology</subject><subject>Review</subject><subject>Review Article</subject><subject>SARS-CoV-2</subject><subject>Vaccines</subject><subject>Viral Vaccines - chemistry</subject><subject>Viral Vaccines - immunology</subject><subject>World Health Organization</subject><issn>0019-5456</issn><issn>0973-7693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OHDEMxyPUCij0BXqo5thLivM9uVSiSz-QkEAq6jXKZDzbQbOTbTKziBvvwBv2SUhZQO2Fky3777_tHyHvGHxkAOYoMw62psCBgpBG0esdsg_WCGq0Fa9KDsxSJZXeI29yvgLgFrTdJXuC1zXUzO6Tzz99CP2I1fHS92OeqkXc9C1ltjrpM_qM1Z_bu-oiYcZxqn5MfppzFbvqBDc4xPWqVA_J684PGd8-xgNy-fXL5eI7PTv_dro4PqNBMT5R1bZeWBmaOshWdrpT4BVq2TaSNSA7ZgRwUy5EHWrdSsaxa5Q2XpramyAOyKet7XpuVtiGsjn5wa1Tv_LpxkXfu_87Y__LLePGGanLs3Ux-PBokOLvGfPkVn0OOAx-xDhnx6Ww1ijGRJHyrTSkmHPC7nkNA_eXvduyd4W9e2DvrsvQ-38PfB55gl0EYivIpTUuMbmrOKexMHvJ9h4zTZD0</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Dutta, Ashok Kumar</creator><general>Springer India</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201001</creationdate><title>Vaccine Against Covid-19 Disease – Present Status of Development</title><author>Dutta, Ashok Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus - immunology</topic><topic>Biomedical Research</topic><topic>Coronavirus Infections - immunology</topic><topic>Coronavirus Infections - prevention & control</topic><topic>Coronavirus Infections - virology</topic><topic>COVID-19</topic><topic>COVID-19 Vaccines</topic><topic>Drug Development</topic><topic>Gynecology</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pandemics - prevention & control</topic><topic>Pediatrics</topic><topic>Pneumonia, Viral - immunology</topic><topic>Pneumonia, Viral - prevention & control</topic><topic>Pneumonia, Viral - virology</topic><topic>Review</topic><topic>Review Article</topic><topic>SARS-CoV-2</topic><topic>Vaccines</topic><topic>Viral Vaccines - chemistry</topic><topic>Viral Vaccines - immunology</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dutta, Ashok Kumar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dutta, Ashok Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccine Against Covid-19 Disease – Present Status of Development</atitle><jtitle>Indian journal of pediatrics</jtitle><stitle>Indian J Pediatr</stitle><addtitle>Indian J Pediatr</addtitle><date>2020-10-01</date><risdate>2020</risdate><volume>87</volume><issue>10</issue><spage>810</spage><epage>816</epage><pages>810-816</pages><issn>0019-5456</issn><eissn>0973-7693</eissn><abstract>The pandemic declaration of Covid-19 disease by World Health Organization (WHO) and subsequent widespread morbidities and mortalities in almost all countries of the world led to the research and development to find out a vaccine against SARS-CoV2 virus. Normally any new vaccine development takes 10–15 y time but the search for vaccine against SARS-CoV2 is going on at a very fast pace resulting in almost breakthrough in vaccine development by several research institutions and vaccine manufacturers. In pandemic situation, however, the entire process of vaccine development including clinical trials gets shortened and may be fast tracked to 15–18 mo time. It is expected that there shall be simultaneous marketing of several vaccines by the beginning of 2021. There are more than 164 candidate vaccines which are in the process of development and among them 24 vaccines are in advanced stages of development. This review aims at highlighting the present stages of development of vaccines and discussing the challenges that may be faced with these novel vaccines.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>32880819</pmid><doi>10.1007/s12098-020-03475-w</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0019-5456 |
| ispartof | Indian journal of pediatrics, 2020-10, Vol.87 (10), p.810-816 |
| issn | 0019-5456 0973-7693 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7468088 |
| source | Springer Link |
| subjects | Betacoronavirus - immunology Biomedical Research Coronavirus Infections - immunology Coronavirus Infections - prevention & control Coronavirus Infections - virology COVID-19 COVID-19 Vaccines Drug Development Gynecology Humans Medicine Medicine & Public Health Pandemics - prevention & control Pediatrics Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control Pneumonia, Viral - virology Review Review Article SARS-CoV-2 Vaccines Viral Vaccines - chemistry Viral Vaccines - immunology World Health Organization |
| title | Vaccine Against Covid-19 Disease – Present Status of Development |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T22%3A57%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccine%20Against%20Covid-19%20Disease%20%E2%80%93%20Present%20Status%20of%20Development&rft.jtitle=Indian%20journal%20of%20pediatrics&rft.au=Dutta,%20Ashok%20Kumar&rft.date=2020-10-01&rft.volume=87&rft.issue=10&rft.spage=810&rft.epage=816&rft.pages=810-816&rft.issn=0019-5456&rft.eissn=0973-7693&rft_id=info:doi/10.1007/s12098-020-03475-w&rft_dat=%3Cproquest_pubme%3E2439975113%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c512t-5dda394cb8c4d4f6f50a5e64db41b04f173027290e6c86d412efb567a478a7c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2439975113&rft_id=info:pmid/32880819&rfr_iscdi=true |